Spring 2011 - Safety

Albuterol Inhalation Solution Voluntarily Recalled from Market

The Ritedose Corp. is voluntarily recalling its 0.083% Albuterol Sulfate Inhalation Solution, 3 mL in 25-, 30- and 60-unit dose vials.The product, which is a prescription inhalation solution administered via nebulization for the treatment and maintenance of acute asthma exacerbations and exercise-induced asthma in children and adults, is being recalled because the 2.5 mg/3 mL single-use vials are embossed with the wrong concentration of 0.5 mg/3 mL and, therefore, represent a potential significant health hazard.

The following lot numbers manufactured by The Ritedose Corp. under NDC: 0591-3797-83, 0591-3797-30 and 0591- 3797-60 are included in the recall: 0N81, 0N82, 0N83, 0N84, 0NE7, 0NE8, 0NE9, 0NF0, 0P12, 0P13, 0P46, 0P47, 0PF0 and 0S15. Consumers should return the affected product to the place it was obtained. Wholesalers and retailers should return the product to: Total Product Destruction, Attn: Recall, 8025 Howard St., Spartanburg, SC 29303. For more information, call (803) 935-3995 or email [email protected].

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.